Blansko, Czechia

Libor Vyklicky

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.7

ph-index = 1


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Libor Vyklicky: Innovator in Pharmaceutical Processes

Introduction

Libor Vyklicky is a notable inventor based in Blansko, Czech Republic. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for preparing complex compounds. With a total of 2 patents to his name, Vyklicky continues to push the boundaries of innovation in his industry.

Latest Patents

Vyklicky's latest patents include a process for preparing ozanimod, which relates to the preparation of a compound of formula (1) or a salt thereof. This invention also encompasses intermediates used in the process. Another significant patent is for an improved process for preparing Idelalisib, where acid addition salts of idelalisamine serve as useful intermediates for purification purposes. These inventions highlight his expertise in chemical processes and their applications in medicine.

Career Highlights

Libor Vyklicky is currently associated with Synthon B.V., a company known for its focus on developing complex pharmaceuticals. His work at Synthon has allowed him to refine his skills and contribute to groundbreaking advancements in drug development. His dedication to innovation is evident in the patents he has secured, which reflect his commitment to improving pharmaceutical processes.

Collaborations

Vyklicky has collaborated with talented individuals such as Marian Buchlovic and Lenka Chalupova. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their work.

Conclusion

Libor Vyklicky stands out as a prominent inventor in the pharmaceutical industry, with a focus on innovative processes that enhance drug development. His contributions through patents and collaborations demonstrate his commitment to advancing the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…